PeriPharm
This is a cross-sectional, real-world observational, community pharmacy-based study in which adults treated with a triptan for their migraine will self-report productivity and activity impairment using a web-based portal or paper-based questionnaire.
Migraine
observational study
The primary objective of this study is to estimate the productivity and activity impairment associated with migraine in adults treated with a triptan. Participant identification will be made using pharmacies member of the PROxy Network. Eligible participants will be identified using the prescription of any formulation of triptans either when filling or refilling a prescription of a triptan or in the pharmacy electronic database (patients with a renewal in the last 3 months). The PROxy Network is a research network bringing together community pharmacies across Quebec to facilitate the generation of real-world evidence. This network is designed to better understand a disease or a treatment using patient-reported outcomes (PROs). The PROxy Network is an initiative of PeriPharm Inc., a company specializing in pharmacoeconomics and outcomes research.}}
| Study Type : | Observational |
| Estimated Enrollment : | 100 participants |
| Official Title : | The Impact of Migraine on Canadians' Productivity: A Real-World Pharmacy-Based Study |
| Actual Study Start Date : | October 31, 2022 |
| Estimated Primary Completion Date : | March 6, 2023 |
| Estimated Study Completion Date : | March 6, 2023 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Accepts Healthy Volunteers |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
PROxy Network, an initiative of PeriPharm inc.
Montreal, Quebec, Canada, H2Y 2H4